Merck and Co. generates the majority of its worldwide revenue from its pharmaceutical operating segment. Sales from the company’s oncology business, which focuses on drugs that treat cancer, accounted for the largest single share of its pharmaceutical revenue in 2021.
Revenues boosted by sales of cancer treatments
Merck & Co. is a global healthcare company that generated approximately 48.7 billion U.S. dollars in total revenue in 2021. The company has two reportable operating segments: pharmaceutical and animal health. The pharmaceutical segment is split into ten franchises - or therapeutic areas; oncology generated nearly 19 billion U.S. dollars in 2021 – a significant increase compared to the previous year. Sales of cancer drug Keytruda were particularly strong and increased from 7.17 billion in 2018 to 17.2 billion U.S. dollars in 2021.
An overview of Merck’s global operations
The corporate headquarters of Merck & Co. is located in New Jersey, and the company’s domestic market is the region that continues to generate the most of its revenue. Outside of the United States, Merck & Co. has operations in Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company’s sales in the Asia Pacific (excluding China and Japan) region stayed almost the same between 2019 and 2021. Operating business strategies in emerging markets, such as China, can come with challenges, but they offer huge potential for growth over time.
Pharmaceutical revenue of Merck & Co. in 2021, by therapy area
(in million U.S. dollars)
* These amounts do not reflect sales of vaccines sold in most major European markets through the Company’s joint venture, Sanofi Pasteur MSD, the results of which are reflected in Equity income from affiliates. These amounts do, however, reflect supply sales to Sanofi Pasteur MSD.
** Other
pharmaceutical
primarily
reflects
sales
of
other
human
health
pharmaceutical
products,
including
products
within
the
franchises
not
listed
separately.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Merck & Co.. (February 25, 2022). Pharmaceutical revenue of Merck & Co. in 2021, by therapy area (in million U.S. dollars) [Graph]. In Statista. Retrieved May 21, 2022, from https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co.. "Pharmaceutical revenue of Merck & Co. in 2021, by therapy area (in million U.S. dollars)." Chart. February 25, 2022. Statista. Accessed May 21, 2022. https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co.. (2022). Pharmaceutical revenue of Merck & Co. in 2021, by therapy area (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 21, 2022. https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co.. "Pharmaceutical Revenue of Merck & Co. in 2021, by Therapy Area (in Million U.S. Dollars)." Statista, Statista Inc., 25 Feb 2022, https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co., Pharmaceutical revenue of Merck & Co. in 2021, by therapy area (in million U.S. dollars) Statista, https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/ (last visited May 21, 2022)
